|
1#

楼主 |
发表于 2008-4-17 21:26:28
|
只看该作者
Asia's M&A market shows its mettle
The mergers and acquisition market in Asia is holding up better than in Europe and North America, underlining easier access to funds in the region and the global expansion drive by Chinese and Indian companies, according to bankers.
Since the start of January, M&A transactions in Asia-Pacific have amounted to $236.5bn, a fall of 5.8 per cent from a year earlier, according to data from Dealogic. By comparison, the M&A declines in Europe and North America are respectively 31.8 per cent and 37 per cent.
Chinese and other Asian investors are injecting capital into Western financial services companies that have been hit by the collapse of the US subprime market.
Ed King, M&A head for Asia-Pacific at Morgan Stan-ley, said: “In a number of Asian markets local banks continue to provide acquisition finance, making it easier for deals to complete successfully.”
Chinese companies are leading an attempt by Asian nations that rely on imports of oil, gas and metals to gain control over resources in commodities-rich countries such as Australia. Chinese M&A volumes have doubled this year.
Acquisitions in India this year include Tata Group's $2.3bn purchase of Jaguar and Land Rover from Ford.
“Asian corporates have come of age,” said Robert Morse, Asia-Pacific chief executive of Citi's institutional clients group. “Some of these headline-grabbing transactions would have been unimaginable just a few years ago. But strong balance sheets, top-class management teams and access to capital are driving Asia Inc to search out opportunities across the globe to grow their businesses.”
For Asia, the value of domestic and inbound transactions has fallen 15.3 per cent from the same period last year, according to Dealogic, compared with falls in Europe and North America of 34.4 per cent and 28.2 per cent respectively. However, Asia's performance has been clouded by the weakness of the Japanese market, in spite of this month's $8.8bn offer from Takeda, Japan's largest pharmaceuticals company, for Millennium Pharmaceuticals of the US.
Since January, the value of Japanese M&A deals has fallen 15.8 per cent. Excluding outbound deals, it is down 31.2 per cent in line with the drop in Europe and North America. |
|